Währungen / INTS
INTS: Intensity Therapeutics Inc
0.28
USD
0.01
(3.45%)
Der Wechselkurs von INTS hat sich für heute um -3.45% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 0.28 bis zu einem Hoch von 0.30 gehandelt.
Verfolgen Sie die Intensity Therapeutics Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
INTS News
- Benchmark lowers Intensity Therapeutics stock price target to $1.50 on dilution
- Brookline Capital upgrades Intensity Therapeutics stock rating to Buy
- Intensity Therapeutics regains compliance with Nasdaq listing requirements
- Intensity Therapeutics shareholders elect director and approve auditor at annual meeting
- Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.24%
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories - TipRanks.com
- Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results - CureVac (NASDAQ:CVAC), Helius Medical Tech (NASDAQ:HSDT)
- Dow Tumbles Over 100 Points; US Producer Prices Edge Higher In May - Healthcare Triangle (NASDAQ:HCTI), Greenlane Hldgs (NASDAQ:GNLN)
- Intensity Therapeutics, Inc. Announces Pricing of Public Offering
- Intensity Therapeutics announces public offering of common stock
- Intensity’s cancer drug shows tumor necrosis in early-stage study
- Intensity Therapeutics, Inc.’s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment
- Intensity Therapeutics stock hits 52-week low at $0.29
- Benchmark maintains Speculative Buy on Intensity Therapeutics stock
- Intensity stock rating cut to Hold by Brookline Capital
- Why Intensity Therapeutics (INTS) Stock Is Getting Hammered - Intensity Therapeutics (NASDAQ:INTS)
- Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Charles & Colvard (NASDAQ:CTHR), AGM Gr Hldgs (NASDAQ:AGMH)
Tagesspanne
0.28
0.30
Jahresspanne
0.19
4.35
- Vorheriger Schlusskurs
- 0.29
- Eröffnung
- 0.29
- Bid
- 0.28
- Ask
- 0.58
- Tief
- 0.28
- Hoch
- 0.30
- Volumen
- 934
- Tagesänderung
- -3.45%
- Monatsänderung
- 3.70%
- 6-Monatsänderung
- -88.03%
- Jahresänderung
- -93.56%
30 August, Samstag